Bitcoin has gained nearly 30% over the past two weeks
cryptocurrency5 hours ago
Pfizer-BioNTech said Thursday they will test a combined coronavirus and influenza vaccine which could potentially pave the way for better inoculation uptake for both illnesses.
The companies said in a statement the mRNA-based combination vaccine candidate was set to progress to a phase one trial in the United States with 180 volunteers.
The inoculation "could simplify immunisation practices against these two respiratory pathogens, potentially leading to better vaccine uptake for both diseases," said Annaliesa Anderson, head of vaccine research and development at US drugmaker Pfizer.
"Even with existing seasonal influenza vaccines, the burden of this virus is severe across the world, causing thousands of deaths and hospitalisations every year."
Pfizer and its German partner BioNTech developed one of the most widely used vaccines to combat Covid-19.
Rival vaccine makers Moderna and Novavax have also been testing combined inoculations against Covid and flu.
ALSO READ:
Bitcoin has gained nearly 30% over the past two weeks
cryptocurrency5 hours ago
Antitrust officials said in the filing that Google should also be made to sell Android i
tech5 hours ago
Global philanthropists call for stronger networks, governance, and data-driven impact measurement
business6 hours ago
The Sri Lankan legend, who met amateur cricketers in Dubai, named Kohli among the greatest batters of all time
cricket6 hours ago
Nasdaq-listed MakeMyTrip emerges as the market leader in UAE’s OTA air landscape
business6 hours ago
Self-reliant India Mission showing striking results in the defence sector
business6 hours ago
Parte Gulfeh is dedicated to upholding historic Chivalric traditions
business6 hours ago
The vessel was 10 nautical miles from Zirku Island
uae6 hours ago